Jun 6 |
AZTR: Netherton Syndrome Review and ATR-12 Clinical Trial
|
Jun 3 |
AZTR: Pipeline Review
|
May 31 |
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention
|
May 17 |
Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting
|
May 10 |
Azitra GAAP EPS of -$0.15
|
May 10 |
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting
|
May 9 |
Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates
|
May 5 |
Wall Street Breakfast: The Week Ahead
|
Apr 22 |
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting
|
Apr 18 |
Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024
|